Phase III, Randomized, Multicenter, Open Label, Non-Inferiority Trial to Explore the Safety and Efficacy of Ticagrelor Compared With Clopidogrel in Patients With ST Elevation Myocardial Infarction Treated With Pharmacological Thrombolysis
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 06 Dec 2017
At a glance
- Drugs Ticagrelor (Primary) ; Clopidogrel
- Indications Acute coronary syndromes
- Focus Adverse reactions
- Acronyms TREAT
- 30 Nov 2017 Planned End Date changed from 1 Aug 2018 to 1 Dec 2018.
- 30 Nov 2017 Status changed from recruiting to active, no longer recruiting.
- 12 Jul 2016 Status changed from not yet recruiting to recruiting.